NCT06996301View on ClinicalTrials.gov

Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.

NACompletedINTERVENTIONAL
Enrollment

773

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

May 31, 2024

Conditions
Urinary Tract Infection ComplicatedUrinary Tract Infection (cUTI)Urinary Tract Infection (Diagnosis)
Interventions
DIAGNOSTIC_TEST

Treatment guided by the PCR results

Patients receive treatment prescribed by a blinded clinician, based solely on the PCR diagnostic results

DIAGNOSTIC_TEST

Treatment guided by the C&S results

Patients receive treatment prescribed by a blinded investigator (clinician), based solely on the C\&S diagnostic results.

Trial Locations (6)

30809

Augusta Urology Associates, Evans

31707

Albany Urology Clinic & Surgery Center, Albany

31768

Colquitt Regional Medical Center, Moultrie

64506

Phoenix Urology of St Joseph, Saint Joseph

73071

Norman Urology Associates, Norman

95124

Silicon Valley Medical Development, San Jose

All Listed Sponsors
collaborator

Dicentra Inc.

INDUSTRY

lead

Doc Lab Inc

INDUSTRY